AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT04819503 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Repetitive transcranial magnetic stimulation (sub-study 2)
Description: After sub-study 1, the same patients will enter sub-study 2 where they are randomly assigned to receive either first active rTMS (10 days over 2 weeks), and then after a 9 week washout period, sham rTMS (10 days over 2 weeks), or they first receive sham rTMS, and then after 9 weeks of washout, active rTMS. Thus, patients undergo stimulation with deep rTMS in a double blinded randomised controlled trial with a 2 x 2 cross-over design, receiving both active and placebo stimulation
Study NCT05328375 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Telehealth-enhanced Hybrid CR
Description: Participants in this group attend a total of 24 CR sessions (5 clinic-based + 19 home-based) over a 12-week period. Clinic-based sessions occur during the first week of the program and at the end of each month. Home-based sessions take place remotely once or twice per week via telehealth, depending on the week of the program. Patients are provided with onboarding sessions, remote patient monitoring devices (tablet, pulse oximeter, blood pressure monitor and cuff) and home-based exercise equipment (e.g., stationary bike and weights). Each CR session (clinic and home) is 60 minutes in duration and includes aerobic and resistance exercise training. Patients will also be asked to complete educational videos, as well as document their physical activity, dietary intake, medication management and homework sessions via surveys. Patients will be encouraged (but not required) to achieve ≥30 minutes of moderate aerobic activity, such as brisk walking, on ≥5 days per week.
Study NCT05328375 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Traditional CR
Description: Participants in this group attend a total of 24 clinic-based CR sessions according to standard of care protocols over a 12-week period. Each CR session is 60 minutes in duration and includes aerobic and resistance exercise training. In addition to scheduled sessions, patients will be asked to complete educational videos, as well as document their physical activity, dietary intake, medication management and homework sessions via surveys. Patients will be encouraged (but not required) to achieve ≥30 minutes of moderate aerobic activity, such as brisk walking, on ≥5 days per week.
Study NCT06260046 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sufentanil
Description: Induction: sufentanil TCI 0.3 ng/ml Maintenance: sufentanil TCI 0.05-0.5 ng/ml
Study NCT06260046 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Remifentanil
Description: Induction: remifentanil TCI 3 ng/ml Maintenance: remifentanil TCI 0.5-5 ng/ml
Study NCT06309030 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bushen quhan zhiwang decoction
Description: Treatment with 100ml of Bushen quhan zhiwang decoction twice a day for 3 months.
Study NCT06309030 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Bushen quhan zhiwang decoction placebo
Description: Treatment with 100ml of Bushen quhan zhiwang decoction placebo twice a day for 3 months.
Study NCT04908683 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Adenovirus serotype 26 (Ad26)-based respiratory syncytial virus (RSV). preF
Description: Participants will receive a single IM injection of an RSV vaccine.
Study NCT04908683 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Participants will receive a single IM injection of matching placebo.
Study NCT05509543 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: IY-NT-T
Description: Ilaprazole 20mg
Study NCT05509543 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: IY-NT-R
Description: Ilaprazole 10mg
Study NCT05297617 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Anti-aromatase inhibitor
Description: Treatment will be either:~* Letrozole, given per os, 2.5 mg daily~* Anastrozole, given per os, 1 mg daily~* Exemestane, given per os, 25 mg daily
Study NCT04980768 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Root canal treatment
Description: Patients with apical periodontitis will undergo root canal treatment.
Study NCT05742230 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Henagliflozin 10 mg
Description: Participants will receive 10 mg single oral tablets orally once daily.
Study NCT05742230 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: blank control
Description: standard treatment
Study NCT02587572 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Peripheral Intravenous (IV) infusion of LMSCs
Description: Peripheral Intravenous (IV) infusion of LMSCs
Study NCT02587572 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Peripheral Intravenous (IV) infusion of LMSCs
Description: Peripheral Intravenous (IV) infusion of LMSCs
Study NCT05654428 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mckenzie Extension Exercises
Description: The exercises used to create space between under lying structures of lumber spine which help centralization of pain and can be performed in prone lying such as prone press ups, prone on elbow, and head lift in prone.
Study NCT05654428 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: William Flexion Exercises
Description: Exercises for strengthening of gluteal and abdominal muscles which help to reduce pressure on the nerve root by promoting flexion at lumber spine such as knee to chest, double knee to chest, bridging(Gluets bridge), and straight leg raise (SLR).
Study NCT05692531 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: A Story Within A Story
Description: The intervention is the screening via Zoom of A Story Within A Story, two dramatized scenarios. The first depicts a reinforcing feedback loop connecting internalized, anticipated and enacted HIV stigma and serosorting within the Black SGL/MSM community. Set during the COVID-19 pandemic, it depicts a Zoom call among three generations of Black SGL/MSM, a chosen family. In this scene, the oldest member of the family, not knowing that the youngest has just tested positive for HIV, describes how they would never partner with someone who was living with HIV because of what they saw at the beginning of the HIV epidemic. The middle-aged member attempts to mitigate the damage done by this, while the youngest member describes what kind of support he needs. The second scenario depicts a Telehealth visit between a young Black gay man and his sexual health provider; his older lover joins the call at one point and the focus is on sexual communication and PrEP use.
Study NCT05207618 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: ARBOX (QUEBRACHO AND CHESNUT EXTRACT)
Description: ARBOX TWICE A DAY FOR 60 days
Study NCT05328596 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: CBT treatment
Description: CBT-treatment
Study NCT05328596 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Wait list control
Description: No intervention
Study NCT06387667 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Complete blood count
Description: blood sample
Study NCT06387667 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: C-reactive protein, urea, creatinine, Random blood glucose (RBG), aspartate aminotransferase (AST), alanine aminotransferase (ALT)
Description: serum sample
Study NCT06387667 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: CT chest
Description: Computed tomography of the chest
Study NCT06387667 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Microscopic examination
Description: sputum and bronchoalveolar lavage (BAL)
Study NCT06387667 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: culture and sensitivity
Description: for bacterial and fungal
Study NCT05491525 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vibegron
Description: Participants will be administered Vibegron orally, once daily (QD)
Study NCT05462223 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Alucent Vessel Restoration System for AVF
Description: Alucent Vessel Restoration System for AVF (VRS-AVF) consists of the following components:~1. VRS 10-8-10 Dimer Coated Balloon Catheter for AVF~2. VRS Light Fiber~3. VRS Light Source
Study NCT04553640 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Group A/Intervention Curriculum
Description: Virtual patient cases and feedback
Study NCT04553640 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Group A/Intervention Curriculum
Description: Virtual patient cases and feedback
Study NCT04553640 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Group B/Control Curriculum
Description: Online articles on dizziness and emergency department clinical experience
Study NCT04553640 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Group B/Control Curriculum
Description: Online articles on dizziness and emergency department clinical experience
Study NCT05731869 — intervention group
Intervention type: OTHER
Intervention: epicondylitis band
Description: An off-the-shelf lateral epicondylitis tape in S-M-L dimensions was used distal to the lateral epicondylitis.
Study NCT05731869 — intervention group
Intervention type: OTHER
Intervention: wrist orhosis
Description: Wrist orthosis of the shelf was used in sizes S-M-L, covering the hand and wrist.
Study NCT05100368 — intervention group
Intervention type: OTHER
Intervention: patients
Description: Patients with Ewing's Sarcoma and osteosarcoma with established diagnosis
Study NCT00122122 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Enhanced Pharmacy Care
Study NCT05592561 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: mental stress task
Description: The stress protocol used for this experiment utilized a cognitive challenge and a previously studied virtual reality active shooter drill (VR-ASD). The cognitive challenge included a modified version of the Stroop challenge (2 min) and mental arithmetic calculations (2 min) presented to the subject via e-Prime 2 software (Psychology Software Tools, Inc., Pittsburgh, PA, USA). Immediately upon completion of the cognitive challenge, the subjects completed the VR-ASD scenario (\~2 min) followed by the same cognitive challenge with different questions (another 4 min). The total duration was \~10 min.
Study NCT05592561 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: mental stress task
Description: The stress protocol used for this experiment utilized a cognitive challenge and a previously studied virtual reality active shooter drill (VR-ASD). The cognitive challenge included a modified version of the Stroop challenge (2 min) and mental arithmetic calculations (2 min) presented to the subject via e-Prime 2 software (Psychology Software Tools, Inc., Pittsburgh, PA, USA). Immediately upon completion of the cognitive challenge, the subjects completed the VR-ASD scenario (\~2 min) followed by the same cognitive challenge with different questions (another 4 min). The total duration was \~10 min.
Study NCT06184113 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Aortic valve replacement surgery
Description: Patients undergoing first-time isolated aortic valve replacement with a rapid deployment biological prosthesis.
Study NCT06184113 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Aortic valve replacement surgery
Description: Patients undergoing first-time isolated aortic valve replacement with a rapid deployment biological prosthesis.
Study NCT06184113 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Computed tomography
Description: All the study patients will undergo a computed tomography imaging to assess for hypo-attenuated leaflet thickening and reduced leaflet mobility of the biological prosthesis following the three-month treatment period.
Study NCT06184113 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Computed tomography
Description: All the study patients will undergo a computed tomography imaging to assess for hypo-attenuated leaflet thickening and reduced leaflet mobility of the biological prosthesis following the three-month treatment period.
Study NCT06184113 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Echocardiography
Description: All the study patients will undergo a transthoracic echocardiography before hospital discharge and following the three-month treatment period.
Study NCT06184113 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Echocardiography
Description: All the study patients will undergo a transthoracic echocardiography before hospital discharge and following the three-month treatment period.
Study NCT04318171 — intervention group
Intervention type: DEVICE
Intervention: 3D Imaging.
Description: When the normal Doppler assessment is done following nationally approved protocol for scanning Carotid arteries, lower and upper limb arteries, AVF and Vein mapping. PIUR tUS infinity system 3D Bluetooth motion sensor which is linked to video transmission box will be used to scan the patient's common carotid artery (CCA), internal carotid artery (ICA) and external carotid artery (ECA) in transverse view to obtain the following measurements:~* Plaque volume where detectable.~* Max area stenosis.~* Volumetric stenosis.~* Measured length.~* 3D GSM. The entire assessment should not take more than 45 minutes.
Study NCT05567432 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: thyroidectomy
Description: use diathermy or ligasure for homeostatic during thyroidectomy
Study NCT05296902 — intervention group
Intervention type: DEVICE
Intervention: Mucosal Closure
Description: mucosal closure in oral surgery (mucosal sutures)
Study NCT06217783 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Introcan Safety IV Catheter
Description: Given by IV
Study NCT06260033 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biospecimen Collection
Description: Undergo blood sample collection
Study NCT06260033 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Bone Scan
Description: Undergo bone scan
Study NCT06260033 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Computed Tomography
Description: Undergo PET/CT scan
Study NCT06260033 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: F-18 16 Alpha-Fluoroestradiol
Description: Given IV
Study NCT06260033 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Positron Emission Tomography
Description: Undergo PET/CT scan
Study NCT06260033 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaire Administration
Description: Ancillary studies
Study NCT06260033 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Stereotactic Body Radiation Therapy
Description: Undergo SBRT
Study NCT05435625 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: FCO2
Description: Fractional Carbon dioxide laser
Study NCT05435625 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: FRF
Description: Fractional Microneedling Radiofrequency
Study NCT05222152 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Chronocort
Description: Hydrocortisone modified-release hard gelatin capsules for oral administration - 5mg and 10mg
Study NCT05222152 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Plenadren
Description: Hydrocortisone modified-release tablets for oral administration - 5mg and 20mg
Study NCT04868981 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GST-HG141 tablets
Description: Administrate GST-HG141 tablets orally in fed state twice daily at 25 mg or 50mg or 100 mg doses
Study NCT04868981 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Matching Placebos for GST-HG141 tablets
Description: Administrate the placebos for GST-HG141 tablets orally in fed state twice daily at 25 mg or 50mg or 100 mg doses
Study NCT06374277 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Med AAAction intervention
Description: The Med AAAction intervention will include the following components: 1) medications with zero copay, 2) bedside delivery and subsequent home delivery of medications, and 3) care coordination provided by certified pharmacy technicians/health coaches to assist with medication access, medication reconciliation, and rapid and ongoing primary care follow-up after hospital discharge. The intervention will be provided for one-year.
Study NCT06374277 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Med AAAction intervention
Description: The Med AAAction intervention will include the following components: 1) medications with zero copay, 2) bedside delivery and subsequent home delivery of medications, and 3) care coordination provided by certified pharmacy technicians/health coaches to assist with medication access, medication reconciliation, and rapid and ongoing primary care follow-up after hospital discharge. The intervention will be provided for one-year.
Study NCT05432947 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 68Ga-P16-093
Description: Intravenous injection of 68Ga-P16-093 with a dosage of 1.8-2.2 MBq (0.05-0.06 mCi)/kg.
Study NCT05432947 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 18F-FDG
Description: Intravenous injection of 18F-FDG with a dosage of 5.55 MBq (0.15 mCi)/kg.
Study NCT04873102 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Danazol Pill
Description: Danazol is a synthetic steroid derived from ethisterone, It suppresses the pituitary-ovarian axis by inhibiting the pituitary output of gonadotropins. The pituitary-suppressive action of danazol is reversible. Danazol has been approved in treating endometriosis, fibrocystic breast disease, hereditary angioedema, thrombocytopenic purpura, and other conditions. It is metabolized and eliminated by renal and fecal pathways. The mean half-life of danazol in healthy males is 9.7 hours. After 6 months of 200 mg three times a day dosing in endometriosis patients, the half-life of danazol was reported as 23.7 hours.~Adverse reactions from danazol include androgen like effects (i.e. weight gain, acne, mild hirsutism, edema, hair loss, voice change) and menstrual disturbances. The use of danazol in pregnancy is contraindicated. Other side effects include elevations in liver-enzyme levels and lipid abnormalities.
Study NCT06298695 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Individual Schema Therapy
Description: Schema therapy focuses on adapting maladaptive schemas (i.e., core representations of oneself, others or the world) and dysfunctional personality traits, while also incorporating exposure therapy. It consists of a maximum of 40 sessions within one year.
Study NCT06298695 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: TAU
Description: Treatment As Usual according to the Dutch Multidisciplinary Guidelines Anxiety Disorders and the Dutch Quality Standard for Anxiety Disorders. TAU often consists of a continuation of Cognitive Behavioral Therapy (CBT) and (different) medications, sometimes in a more treatment-intensive format. There are no restrictions to TAU, except that it may not be schema therapy. The actual content of TAU will be tracked.
Study NCT06312111 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: recommendation to increase physical activity
Description: education on the benefits of physical activity in PAH from the first visit and doctor's recommendation to increase physical activity above 5,000 steps a day in inactive patients and above 5,000 steps per person in active patients
Study NCT06312111 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: recommendation to increase physical activity
Description: education on the benefits of physical activity in PAH from the first visit and doctor's recommendation to increase physical activity above 5,000 steps a day in inactive patients and above 5,000 steps per person in active patients
Study NCT05030909 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: transdiagnostic group treatment
Description: The individual and group sessions will integrate core principles from Motivational interviewing (provide information, address barriers), Cognitive Behavioural Therapy (psychoeducation regarding emotions, enhancing emotional awareness, cognitive restructuring, behavioural experiments, relaxation) , Acceptance Commitment Therapy (mindfulness, grounding, emotional and body awareness, enhancing cognitive flexibility), and aspects of Islamic psychology.
Study NCT05030909 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: transdiagnostic group treatment
Description: The individual and group sessions will integrate core principles from Motivational interviewing (provide information, address barriers), Cognitive Behavioural Therapy (psychoeducation regarding emotions, enhancing emotional awareness, cognitive restructuring, behavioural experiments, relaxation) , Acceptance Commitment Therapy (mindfulness, grounding, emotional and body awareness, enhancing cognitive flexibility), and aspects of Islamic psychology.
Study NCT05366985 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Socket shield technique with computer guided sectioning of the root
Description: A computer guide was used to section the root, leaving the coronal 2/3 of its labial part attached to the socket. An implant was then placed.~Preoperative and Postoperative (5 months later) intraoral scans were superimposed with a digital software to assess the dimensional changes of the labial alveolar ridge. Linear changes at 1,3 and 5 mm from the gingival margin and mean linear changes in a specified Area Of Interest (AOI) were measured
Study NCT05319743 — intervention group
Intervention type: OTHER
Intervention: Medicaid Expansion
Description: Expansion of Medicaid, 01/01/2014
Study NCT05153148 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NDI-034858
Description: NDI-034858 oral capsule
Study NCT05153148 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: NDI-034858-matching oral placebo capsule